2218 Kausen Dr., Suite 130
Elk Grove, CA 95758
Ph: 916-683-8774
Fax: 916-683-8777

• University of Massachusetts
  Medical School Fellowship in Nephrology Worcester, MA
  July 2005 - June 2007

• University of Massachusetts Medical School Chief Resident,
  Internal Medicine Residency Program Worcester, MA
  July 2004 - June 2005

• University of Massachusetts Medical School Categorical,
  Internal Medicine Residency Program Worcester, MA
  July 2001 - June 2004

• St. George's University School of Medicine
  Medical Doctorate Degree Grenada, WI / Bay Shore, NY
  August 1997 - June 2001

• University of California, Los Angeles
  Bachelor of Science Psychology Los Angeles, CA
  Sept 1991 - June 1995

• American Board of Internal Medicine,
  Board Eligible in Nephrology
  July 2007

• American Board of Internal Medicine Certification
  August 2005 - Devember 2015

• Massachusetts Medical Licensure
  March 2005 - 2007

• California Licensure
  2006

• National Kidney Foundation
  2006 - Present

• American Society of Nephrology
  2006 - Present

• Renal Physicians Associations
  2006 - Present

• Massachusetts Medical Society,
  Resident Physicians Fellowship appointed Communications Committee Representative
  2003 - 2004

• Massachusetts Medical Society
  2001 - Present

• American College of Physicians, American Society of Internal Medicine
  2001 - Present

• University of Massachusetts Medical School
  3rd Year Medical Student Renal Lecture Series: Acute Renal Failure
  2006 - 2007

• University of Massachusetts Graduate School of Nursing,
  Worcester, MA Renal Lecure Series: Acute Renal Failure
  2006 - 2007

• University of Massachusetts Medical School,
  Dept. of Medicine, Resident Noon Conference: Neflhrolithiasis
  August 2006

• University of Massachusetts Medical School,
  Worcester, MA Clinical Instructor
  2005 - Present

• University of Massachusetts Medical School, Worcester, MA Chief Resident Conducted Morning Reports and Noon Conferences Involved in Administrative Duties Within the Department of Medicine
  2005 - 2006

• University of Massachusettes Medical School,
  Worecester, MA Physical Diagnosis Instructor for Second Year Medical Students
  2005 - 2006

• Pleiotropic Effects of Starins in Patients with Hypertension and Microalbuminuria.
  Under John Danziger, M.D., Division of Renal Medicine.
  Massachusetts Medical Center, Worcester, MA (Under IRB Review)
  2006 - 2007

• Study of Cox-2 Expression
  Division of Renal Medicine
  Brookdale University Hospital, Brooklyn, NY
  Performed Immunohistochemical Studies and Nephrectomies
  2000 - 2001

• Lab Assistant / Researcher
  Division of Pediatric Hematology / Oncology
  University of California, Los Angeles Medical Center
  Studied Various Aspect of Ofn-Myc Expression in Neuroblastoma
  1992 - 1995

• Wada, RK; Pai, DS; Huang, J; Yamashiro, JM; Sidell, N: "Interferon-Gamma and Retinoic Acid Down Regulate N-myc in Neuroblastoma Through Complimentary Mechanism of Action" Cancer Letter 1997 Dec 23; 121(2):181-8

• Goodman, LA; Lui, BC; Thiele, CJ; Schmidy, ML; Cohn, SL; Yamashiro, JM; Pai, DS; Ikegaki, N; Wada, RKl "Modulation of N-myc Expression Alters the Invasiveness of Neuroblastoma" Clinical Experimental Metastasis. 1997 Mar; 15(2) 130-9

• Woodruff, KA; "Cell Type Specific Activity of the N-myc Promoter in the Human Neuroblastoma Cells is Mediated by a Down Stream Silencer" Oncofene 1995 Apr 6; 10(7): 1335-41

• Iota Epsilon Alpha Honor Society Member, St. Gorge's University School of Medicine, 1997 - 2001

• Dean's List, St. George's University School of Medicine, 1997 - 2001

• Geoffery Boune Scholarship Recipient, St. George's University, School of Medicine

A Phase III, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multi-Center Trial Evaluating the Efficacy and Safety of XXX in Adult Patiets on Chronic Haemodialysis.

A Phase III, Randomized, Active-Controlled, Open-Label, Multi-Center Study of the Safety and Efficacy of XXX Injection for the Maintenance Treatment of Anemia in Hemodialysis Patients Previously Treated with Epogen.

A Phase IV, Long Term, Observational Safety Study in End Stage Renal Disease Subjects Treated with XXX.

A Phase II, Randomized Double-Blind, Placebo-Controlled, Multi-Center, to Evaluate the Safety and Efficacy of XXX in Patients with Nephropaty Due to Type 2 Diabetes.

Patient Focus Group for Qualatative Assessment of Anemia Associated with Chronic Kidney Disease.

A Multicenter, Randomized, Double-Blink Study to Evaluate the Efficacy and Safety of XXX in Patients with Type 2 Diabetes Mellitus and End Stage Renal Disease Who Are on Dialysis and Who Have Inadequate Glycemic Control.

A Phase II Study of the Safety and Efficacy of XXX Injection for the Maintenace Treatment of Anemia in Subjects with Chronic Renal Failure on Hemodialysis, of Do Not Requre Dialysis and Previously Treated with Darbepoetin Alfa.

The National Institutes of Heath (NIH) Office of Extramural Research Certifies that Dr. Pai Successfully Completed the NIH Web-Based Training Course "Protecting Human Research Participants" 07-01-2009. Certification Number 250174.